TNF and Schwartz-Jampel syndrome: Furthermore, by inducing an SJS/TEN‐like event in healthy skin explants with TNF‐α, and inhibiting it with etanercept, we have a valid model system with the potential to be used for screening targeted therapies for potential therapy in SJS/TEN.